http://www.masshightech.com/latestnews.html Mass High Tech: The Journal of New England Technology : breaking news from Mass High Tech Thu, 18 Mar 2010 08:03:48 -0400 en-US http://www.masshightech.com/ http://www.masshightech.com/images/flag.gif http://www.masshightech.com/stories/2010/03/15/daily38-Babsons-Rice-joins-WPI-as-first-ever-academic-dean.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Worcester Polytechnic Institute has a new dean of business in former Babson College dean Mark P. Rice, who will be succeeding McRae Banks, who has led WPI’s Department of Management for the past 15 years. http://www.masshightech.com/stories/2010/03/15/daily37-IBM-launches-business-plan-competition-in-Boston.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology IBM Corp. today announced the launch in Boston of a startup business-plan competition, in which the company will look to partner with five Boston-area technology companies with less than $1 million in revenue. http://www.masshightech.com/stories/2010/03/15/daily36-Covidien-plans-buyback-of-up-to-1-billion.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Irish medical device maker Covidien PLC, which has its U.S. headquarters in Mansfield, announced today that its board of directors approved a plan to buy back up to $1 billion of the company’s stock, based on market conditions. http://www.masshightech.com/stories/2010/03/15/daily35-Alkermes-launches-Phase-1-trial-for-chronic-pain-drug-candidate.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Alkermes Inc. has launched an early stage drug trial for a potential treatment, ALKS 37, for side effects of opiod use for patients will chronic pain. http://www.masshightech.com/stories/2010/03/15/daily34-Cambridge-Heart-reduces-salaries-eliminates-board-fees.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology The Cambridge company said the affected employees and directors have been awarded stock options to make up for the direct-pay cuts. http://www.masshightech.com/stories/2010/03/15/daily33-Molecular-Insight-receives-Nasdaq-listing-warning.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology According to a Molecular Insight press release, the company has not met the Nasdaq minimum of $50 million for its market value of listed securities for 30 consecutive business days before Mar. 9, the date of the letter. http://www.masshightech.com/stories/2010/03/15/daily32-Quick-Hit-scores-distribution-deal-with-IGN-for-football-game.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Social sports games developer Quick Hit Inc. has signed a distribution deal with the largest gaming site on the web, IGN, which will make the game available through its network of sites, including Direct2Drive, FilePlanet, AskMen and IGN.com. http://www.masshightech.com/stories/2010/03/15/daily31-Boston-World-Partnerships-pumped-200-new-jobs-into-city.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Boston World Partnerships celebrated its one year anniversary last night at the Liberty Hotel, releasing data showing that it is responsible for creating 200 new jobs in Boston and retaining 115 jobs, resulting in an economic impact of $38 million in statewide spending. http://www.masshightech.com/stories/2010/03/15/daily30-Boston-iPhone-app-GIS-Data-Hub-win-tech-awards.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Mayor Tom Menino announced Tuesday that the Public Technology Institute (PTI) awarded the city of Boston with two technology awards — for its Citizens Connect iPhone application and its GIS Data Hub. http://www.masshightech.com/stories/2010/03/15/daily29-ALS-Therapy-Institute-pairs-with-NJ-biotech.html Wed, 17 Mar 2010 00:00:00 -0400 Mass High Tech: The Journal of New England Technology Cambridge-based ALS Therapy Institute has teamed up with a New Jersey biotech to test several small-molecule compounds that have the potential to slow or stop the progression of Amyotrophic Lateral Sclerosis (ALS), commonly called Lou Gehrig's disease.